Decoding the silent walk of COVID-19: Halting its spread using old bullets
Severe acute respiratory syndrome (SARS) develops within 3-14 days when CoV2 invades epithelial, myeloid cells in the nasopharynx and pneumocytes in the respiratory tract through angiotensin converting enzyme (ACE2). Infection swiftly disseminates to gastrointestinal, cardiovascular, renal organs as...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14621
- Acceso en línea:
- https://doi.org/10.1016/j.biopha.2020.110891
http://hdl.handle.net/20.500.12010/14621
- Palabra clave:
- Severe acute respiratory syndrome (SARS-CoV2)
Remedesivir
Chloroquine
Noscapine
Heparin
Vitamin C
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)